Get started

Healthcare

NOTION (0083) - Kajian Potensi TP (TF Weekly) 30/07/2020@09:45pmNOTION VTEC BERHAD (0083) Notion VTec Berhad is an investment holding company. The Company is engaged in providing management services, and provides a range of services from design to production, tooling development, quality assurance, surface coating and finishing, heat treatment, and shipping and logistics. Its segments include Manufacturing and Investing. The Manufacturing segment is engaged in manufacturing precision components and tools, including design, other related activities and incidental services. The Investing segment is engaged in investment holding and provision of management services. Its products include Data Storage, Digital Imaging and Industrial & Automotive. It supplies precision-turned, milled, drilled and ground parts to renowned multi-national companies all over the world. Its services include product development, tooling and fixtures development, process engineering, mechanical machining processes, surface treatment, precision washing technology and waste water treatment. SECTOR: TECHNOLOGY SUB-SECTOR: TECHNOLOGY EQUIPMENT TOTAL SHARE ISSUE: 504,975,973 PUBLIC FLOAT %: 50.73% BERITA TERBAHARU: Pada 9 April 2020, Notion VTec menyatakan kepada Bursa bahawa syarikat itu telah memutuskan untuk menceburkan diri dalam pengeluaran peralatan pelindung diri dan komponen ventilator perubatan berikutan pandemik Covid-19 yang melanda seluruh dunia. Lembaga Pengarah Notion VTec mengumumkan bahawa Notion Venture Sdn Bhd ("NVSB"), anak syarikat milik penuh Notion VTec, telah memperolehi Perakuan Pendaftaran bertarikh 27 Julai 2020 dari Registrar Corp yang mengesahkan bahawa NVSB telah berdaftar dengan U.S. Food and Drug Administration untuk Tahun Kewangan 2020 untuk topeng muka (kecuali alat pernafasan N95) untuk Orang Awam / Personel Penjagaan Kesihatan mengikut Panduan IIE. NVSB juga telah mengirimkan sampel alat pernafasan N95 ke makmal luaran yang diiktiraf dan hasilnya akan durujuk kepada National Institute for Occupational Safety and Health ("NIOSH") untuk kelulusan. Sekiranya kelulusan alat pernafasan N95 diperolehi dari NIOSH, Notion beranggapan bahawa eksport topeng muka akan menjadi perniagaan jangka panjang syarikat. Notion juga mengumumkan bahawa NVSB juga telah menghantar permohonan untuk mendapatkan sijil halal ke Jabatan Kemajuan Islam Malaysia ("JAKIM") dan saat ini sedang menunggu hasil permohonan tersebut. Setelah mendapat perakuan dari JAKIM, Syarikat kemudian akan mengeksport topeng muka ke negara-negara Islam tertentu. ANALISA TEKNIKAL: NOTION mengalami kejatuhan setelah melakukan corak DOUBLE TOP dan harga telah bertahan dan melantun pada EMA50 (TF Weekly) dan seterusnya melakukan reversal. Harga ditutup pada aras RM0.815 pada penutup minggu ini (30/07/2020 - Khamis). Hari Jumaat (31/07/2020) adalah cuti umum sempena Hari Raya Aidiladha. Harga perlu melalui paras halangan Fibonacci yang kuat iaitu 0.382 (RM0.850), 0.500 (RM0.925) dan 0.618 (RM1.00) jika ingin meneruskan kenaikan yang lebih tinggi. #feelfreetodisagree #notAbuycall #tradeatyourownrisk #TAYOR #BursaMalaysia
MYX:NOTIONLong
by yuzieyusoff2
$ALGN can rise in the next daysContextual immersion trading strategy idea. Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $299,35; stop-loss — $279,00. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:ALGNLong
by KozakHlib
$ACOR can rise in the next daysContextual immersion trading strategy idea. Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $0,86; stop-loss — $0,81. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
ALong
by KozakHlib
$PRPO can rise in the next daysContextual immersion trading strategy idea. Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,51; stop-loss — $1,34. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:PRPOLong
by KozakHlib
2
$FIXX can rise in the next daysContextual immersion trading strategy idea. Homology Medicines, Inc., a genetic medicine company, focuses on transforming the lives of patients suffering from rare genetic diseases. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So I opened a long position from $16,45; stop-loss — $15,75. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
FLong
by KozakHlib
$CTIC can rise in the next daysContextual immersion trading strategy idea. CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers. The share prose rose after the company had announced enrollment of first patient in the COVID-19 PRE-VENT phase 3 clinical trial. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $1,38; stop-loss — $1,25. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
CLong
by KozakHlib
$CEMI can rise in the next daysContextual immersion trading strategy idea. Chembio Diagnostics has a strong upward trend. The company develops, manufactures, and commercializes point-of-care diagnostic tests, in particular, COVID-19 tests. This and other conditions can cause a rise in the share price in the next days. I saw it again and opened a long position from $5,03; stop-loss — $4,81. Information about take-profits and stop-loss will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
CLong
by KozakHlib
$BPMC can rise in the next daysContextual immersion trading strategy idea. Blueprint Medicines Corporation develops drugs of small molecule kinase inhibitors that target genomic drivers in genomically defined cancers, rare diseases, and cancer immunotherapy. The share prose rose after the company had announced the deal with pharma giant Roche (RHHBY) to sell a cancer treatment, pralsetinib. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $79,21; stop-loss — $76,47. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:BPMCLong
by KozakHlib
$BLI is giving a GREAT IPO LONG opportunity todayIPO intraday trading strategy idea Berkeley Lights is a leading digital-cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price today. So I opened a long position from $58,00; take-profit — $77,00; stop-loss — $50,00. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas.
BLong
by KozakHlib
1
$RIGL can rise in the next daysContextual immersion trading strategy idea. Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases. The share prose rose after the company had announced that a drug used to treat an autoimmune disorder will be tested in a clinical trial in the United Kingdom as a treatment for COVID-19 pneumonia. The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $2,19; stop-loss — $2,00. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:RIGLLong
by KozakHlib
$FLDM can rise in the next daysContextual immersion trading strategy idea. Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research. The share prose rose after the company had announced that Fluidigm mass cytometry technology and the Maxpar Direct Immune Profiling Assay are being utilized in a prospective observational cohort surveillance study of up to 2,000 adult participants hospitalized with COVID-19. — finance.yahoo.com The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $5,86; stop-loss — $5,41. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
FLong
by KozakHlib
4
$BLFS can rise in the next daysContextual immersion trading strategy idea. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry. The share prose rose after the company had announced preliminary revenue for the second quarter and used the opportunity to raise $75 million — www.fool.com The demand for shares of the company still looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I opened a long position from $19,14; stop-loss — $17,88. Information about take-profits will be later. Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy. If you like my content, you can subscribe to the news and receive my fresh ideas. Thanks for being with me!
NASDAQ:BLFSLong
by KozakHlib
ABT Labs; perfect long-term investmentHello Traders! Abbott Labs had been on a clear and strong uptrend for quite some time before the crisis in March/April. But now that it has recovered and broken out of the short-term downtrend bullishly, the MACD has moved away from the 9 EMA and the RSI is a good bit away from overbought, it is very likely that the price will regain its previous upward momentum and the 50 SMA will take up its role as strong support again. This is a picture-perfect longterm investment! Don't waste this opportunity! VF Investment cannot be held responsible for any financial damages suffered from following our well-funded but personal opinions and trading ideas. Please, maintain proper position sizing and risk management!
NYSE:ABTLong
by vf_investment
Biotechnology Stocks Have Broken OutEveryone’s attention is focused on today’s strong jobs report, but an under-the-radar sector is breaking out: biotechnology. The iShares Nasdaq Biotechnology Index ETF hit new 52-week highs before the rest of the Nasdaq. And it wasn’t just any old breakout. It was the first move above $130 since mid-2015: a historic push to important long-term levels. IBB did something similar in early 2012, closing above its previous high from 2001. It then proceeded to run more than 300 percent before halting. The daily chart has provided some confirmation of the uptrend continuing. After making a new 52-week high in April, it briefly tested below and snapped right back. Then in mid-June when the market had a brief crash, buyers defended IBB’s 50-day simple moving average (SMA). And now in the last two weeks, IBB has broken above and held $133.60, the previous all-time high from five years ago. Has old resistance become new support? Finally, it’s important to consider the macro backdrop: healthcare was already in a secular growth phase because of innovation and ageing populations. The prospect of coronavirus treatments is another positive. Then add a weak economic environment and low interest rates by the Federal Reserve. All of those conditions are supportive for a non-cyclical sector like biotechnology.
NASDAQ:IBB
by TradeStation